Article Details

Concert Pharmaceuticals (NASDAQ:CNCE) Upgraded by StockNews.com to “Hold”

Retrieved on: 2022-11-30 08:24:25

Tags for this article:

Click the tags to see associated articles and topics

Concert Pharmaceuticals (NASDAQ:CNCE) Upgraded by StockNews.com to “Hold”. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 794,106 shares of the biotechnology company's stock valued at $2,675,000 after acquiring an additional 11,293 ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up